title: Current cell-based influenza vaccine production technology as pandemic contingency.
authors.affiliation: Bioprocessing Technology Institute; Agency for Science, Technology and Research (A*STAR); Singapore. ng_say_kong@bti.a-star.edu.sg
authors.forename: Say Kong
authors.initials: SK
authors.lastname: Ng
mesh_terms: D002478:Cells, Cultured; D006801:Humans; D053124:Influenza A Virus, H5N1 Subtype / Q000276:immunology; D007252:Influenza Vaccines; D007251:Influenza, Human / Q000276:immunology / Q000517:prevention & control*; D058873:Pandemics / Q000517:prevention & control*; D004364:Pharmaceutical Preparations / Q000138:chemical synthesis
chemical_list: D007252:Influenza Vaccines; D004364:Pharmaceutical Preparations